Navigation Links
Soligenix Announces Preliminary Results of its Phase 2 Clinical Trial of orBec® in the Prevention of Acute GVHD
Date:10/25/2010

ss release contains forward-looking statements that reflect Soligenix, Inc.'s current expectations about its future results, performance, prospects and opportunities. Statements that are not historical facts, such as "anticipates," "believes," "intends," or similar expressions, are forward-looking statements. These statements are subject to a number of risks, uncertainties and other factors that could cause actual events or results in future periods to differ materially from what is expressed in, or implied by, these statements. Soligenix cannot assure you that it will be able to successfully develop or commercialize products based on its technology, including orBec®, SGX201, RiVax™, and LPM™, particularly in light of the significant uncertainty inherent in developing vaccines against bioterror threats, manufacturing and conducting preclinical and clinical trials of vaccines, and obtaining regulatory approvals, that its cash expenditures will not exceed projected levels, that product development and commercialization efforts will not be reduced or discontinued due to difficulties or delays in clinical trials or due to lack of progress or positive results from research and development efforts, that it will be able to successfully obtain any further grants and awards, maintain its existing grants which are subject to performance, enter into any biodefense procurement contracts with the US Government or other countries, that the US Congress may not pass any legislation that would provide additional funding for the Project BioShield program, that it will be able to patent, register or protect its technology from challenge and products from competition or maintain or expand its license agreements with its current licensors, or that its business strategy will be successful. Important factors which may affect the future use of orBec® for gastrointestinal GVHD include the risks that: the FDA's requirement that Soligenix conduct additional clinical tria
'/>"/>
SOURCE Soligenix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin
2. Soligenix Announces Publication of Positive Pre-Clinical Results with RiVax(TM), Its Vaccine Against Ricin Toxin
3. Soligenix Announces Initiation of a Phase 1/2 Clinical Trial of SGX201 for the Prevention of Acute Radiation Enteritis
4. Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines
5. Soligenix Announces Issuance of Hong Kong Patent for its LPM(TM) Oral Drug Delivery Technology
6. Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration
7. Soligenix to Present at the OneMedForum Conference on Wednesday, June 30 at 2PM EDT
8. Soligenix Announces Award of $1.2 Million FDA Orphan Products Development Grant
9. Soligenix to Present at the Rodman & Renshaw Healthcare Conference on September 15, 2010 at 10AM EDT
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... LONDON and NEW YORK , May ... devices with a detailed analysis of:   - Hospitals and retail ... - Markets such as Indonesia , ... , Singapore , Thailand and ... , New Zealand and Bangladesh ...
(Date:5/5/2015)... 5, 2015  In line with CBME China,s 15 ... community with a charity program to create awareness, draw ... CBME China team is coordinating a donation ... manufacturers, brand owners and distributors. All donated products will ... Proceeds from the sale will be used to support ...
(Date:5/5/2015)... Texas , May 5, 2015  Adeptus Health ... Health") today announced the pricing of the previously announced ... stock, of which 1,349,671 shares are to be sold ... sold by an affiliate of Sterling Partners (the "Selling ... per share. In addition, the Company and the Selling ...
Breaking Medicine Technology:Oceania & ASEAN Respiratory Market to Boost APAC Region Owing to Rising Chronic Respiratory Diseases - Asthma & COPD 2Oceania & ASEAN Respiratory Market to Boost APAC Region Owing to Rising Chronic Respiratory Diseases - Asthma & COPD 3Oceania & ASEAN Respiratory Market to Boost APAC Region Owing to Rising Chronic Respiratory Diseases - Asthma & COPD 4Oceania & ASEAN Respiratory Market to Boost APAC Region Owing to Rising Chronic Respiratory Diseases - Asthma & COPD 5CBME China Launches Charity Program to Support Children with Autism 2Adeptus Health Inc. Announces Pricing of Common Stock Offering 2Adeptus Health Inc. Announces Pricing of Common Stock Offering 3Adeptus Health Inc. Announces Pricing of Common Stock Offering 4
... , ... 20 Reportlinker.com announces that a new ... catalogue. , Global Self Monitoring Blood ... Growth , http://www.reportlinker.com/p0164657/Global-Self-Monitoring-Blood-Glucose-Market-(SMBG )-Increasing-Adoption-to-Drive-Growth.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire ...
... , NEW YORK, ... market research report is available in its catalogue. ... 2009 , http://www.reportlinker.com/p0164742/Global-Markets-for-Assisted-Reproductive-Devices-2009.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire ... U.S., 15 Countries in Europe and Japan. This ...
Cached Medicine Technology:Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 2Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 3Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 4Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 5Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 6Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 7Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 8Reportlinker Adds Global Markets for Assisted Reproductive Devices 2009 2
(Date:5/5/2015)... 05, 2015 Horizon Blue Cross Blue ... and secure credit rating of “A” from Standard & ... last week, the Wall Street ratings agency cited the ... position” in determining the rating and “stable” outlook. , ... of our top priorities, so we are pleased to ...
(Date:5/5/2015)... May 05, 2015 Hundreds ... filed on behalf of men who allegedly ... use of prescription testosterone replacement therapies continue ... litigation underway in U.S. District Court, Northern ... dated May 1st, defendants AbbVie, Inc., Auxilium ...
(Date:5/5/2015)... 05, 2015 Sunny skies and cool temperatures ... as nearly 400 runners and walkers participated in Global Lyme ... nearly $35,000. , The 5K and 10K runs and ... disease and to raise funds for tick-borne disease research. The ... the recent merger of Lyme Research Alliance (LRA) ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 In a April ... The Herald-Times , the Missouri State Highway Patrol (MSHP) ... Methamphetamine production or use for the second year in a ... to the FBI, reported 1,469 incidents in 2014 alone, around ... only around 2% of the US Population calls Indiana home, ...
(Date:5/5/2015)... 05, 2015 The brains of people ... that correlate with slower information processing, according to research ... of Public Health . , The findings indicate ... 1 diabetes for cognitive difficulties. If progressive, these changes ... study, funded by the National Institutes of Health ...
Breaking Medicine News(10 mins):Health News:Horizon Blue Cross Blue Shield of New Jersey Maintains “A” Credit Rating from Standard & Poor’s 2Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 2Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 3Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 4Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 2Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 3Health News:A Forever Recovery Releases New Information on the Epidemic Rise Of Methamphetamine Abuse in Midwest America 2Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 2Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 3Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 4
... Washington: A novel study has portrayed the benefits of subjecting ... reduce the regularity// of antibiotic use. This is perhaps the ... rapid influenza testing on adults. The study is published in ... explain the benefits of this diagnostic tool, revealed that 86 ...
... the January 22 issue of Archives of Internal Medicine, one ... appears to increase// the level of the essential mineral in ... in patients with HIV infection. ,Advances in antiretroviral ... however, strict adherence to the therapy is required to keep ...
... A new research by University of Leeds scientists (UK) discovers ... for our bodies to make their own medicine// and there ... ,Professor Simon Carding of Leeds' Faculty of Biological Sciences ... it produce a treatment for Inflammatory Bowel Disease (IBD). Bacteria ...
... assessing the daily activity patterns of thousands of individuals ... the human circadian// clock becomes coupled to so-called local ... work according to a common "social time" that is ... also indicated that city dwellers appear to experience a ...
... more than a dozen people have taken ill and have ... as ‘false’ and ‘ baseless’ by spokesman Xiong Yuanda of ... there was no infectious ‘unknown’ disease, doing the rounds in ... from the Health bureau has sought to dispel reports carried ...
... diarrhoea and gastro-enteritis among infants and children worldwide, and is ... watery// diarrhea in children younger than five years of age. ... of 20 percent and 38 per cent cases in Pakistan ... Kharadar Hospital, respectively. ,The virus is a ...
Cached Medicine News:Health News:Selenium Supplements May Suppress HIV Viral Load 2Health News:A Spoonful Of Sugar to 'Switch' the Bacteria on and Off 2Health News:Chronotype, a Measure to Assess Patterns of Daily Activities 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: